Business Standard -- Pfizer, which has a tie up with city-based Aurobindo Pharma (APL) on generic supplies, today said it would extend support to the Indian company once they understand the issues related to the USFDA import ban alert. "Once we understand FDA's concerns, we will work with Aurobindo to assist with next steps," Pfizer spokesperson told PTI.
